AXIM BIOTECHNOLOGIES, INC.
AXIM BIOTECHNOLOGIES, INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||||
Convertible Preferred Stock Series B | - | - | - | - | - | - | 0 | - | - | - | 0 | - | |||||
Assets | |||||||||||||||||
Current Assets | |||||||||||||||||
Convertible Preferred Stock Series C | - | - | - | - | 0 | 0 | 0 | 0 | -0 | 1 | 0 | 1 | |||||
Cash | - | - | - | 0 | 0 | - | - | - | - | - | - | - | |||||
Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense Current And Noncurrent | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Prepaid Expense Current | - | - | 0 | 0 | - | 0 | 0 | 0 | 0 | - | 0 | - | |||||
Inventory Net | - | - | - | - | - | - | - | 0 | 0 | 0 | - | 0 | |||||
Other Assets Current | - | - | - | - | - | 0 | 0 | - | - | - | 0 | - | |||||
Supplies | 0 | - | - | - | - | - | - | - | - | - | - | - | |||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Finite Lived Intangible Assets Net | - | - | - | 4 | 4 | - | - | - | - | - | - | - | |||||
Other Intangible Assets Net | 3 | 3 | 4 | - | - | 4 | 4 | - | - | - | 4 | - | |||||
Security Deposit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Other Assets Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 7 | |||||
Inventory Work In Process | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Assets Noncurrent | |||||||||||||||||
Notes Receivable Related Parties | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets | |||||||||||||||||
Other Assets | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 14 | |||||
Goodwill | - | - | - | - | - | - | - | - | - | - | 0 | 2 | |||||
Prepaid Expense Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 14 | |||||
Accounts Payable And Other Accrued Liabilities | - | - | - | - | - | 1 | 1 | - | - | - | 1 | - | |||||
Due To Officers Or Stockholders Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable And Accrued Liabilities Current | 2 | 2 | 3 | 1 | 1 | - | 1 | 1 | 1 | 1 | - | 1 | |||||
Finance Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Derivative Liabilities | - | - | - | - | - | - | - | - | 2 | 2 | - | - | |||||
Liabilities Current | |||||||||||||||||
Capital Lease Obligations | - | - | - | - | - | - | - | - | 0 | 0 | 0 | - | |||||
Liabilities Current | 7 | 5 | 6 | 4 | 8 | 5 | 3 | 3 | 3 | 3 | 3 | 2 | |||||
Operating Lease Liability Current | - | - | - | - | - | - | - | 0 | - | - | - | - | |||||
Capital Lease Obligations Current | - | - | 0 | - | - | - | 0 | - | - | - | 0 | - | |||||
Other Liabilities Current | - | - | 0 | 0 | - | 0 | 0 | - | - | - | 0 | 0 | |||||
Long Term Debt And Capital Lease Obligations Curre… | 0 | 0 | - | 0 | 0 | 0 | - | - | - | - | - | - | |||||
Deferred Revenue Current | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | - | - | - | - | |||||
Unsecured Debt Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 1 | |||||
Notes Payable Current | - | - | - | - | - | - | 0 | - | - | - | 0 | - | |||||
Short Term Borrowings | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Derivative Liabilities Current | 4 | 2 | 2 | 2 | 7 | 1 | 2 | - | - | - | 0 | - | |||||
Deferred Tax Liabilities | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Deferred Income Tax Liabilities Net | - | - | - | - | - | - | - | - | 0 | 0 | - | 2 | |||||
Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | - | 1 | |||||
Deferred Revenue Noncurrent | - | - | - | - | - | - | - | 0 | - | - | - | - | |||||
Deferred Revenue | - | - | - | - | - | 0 | 0 | - | - | - | 0 | - | |||||
Convertible Debt Noncurrent | 5 | 5 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | - | |||||
Convertible Debt Current | - | - | - | - | - | - | - | - | - | - | 1 | - | |||||
Liabilities Noncurrent | |||||||||||||||||
Liabilities Noncurrent | 7 | 7 | 6 | 6 | 6 | 5 | 6 | 6 | 6 | 5 | 5 | 8 | |||||
Convertible Long Term Notes Payable | - | - | - | - | - | - | - | 4 | 4 | 4 | - | 4 | |||||
Liabilities Of Disposal Group Including Discontinu… | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Convertible Notes Payable | - | - | 4 | 4 | 4 | 4 | 4 | - | - | - | 1 | - | |||||
Capital Lease Obligations Noncurrent | - | - | 0 | - | - | - | 0 | - | 0 | 0 | 0 | - | |||||
Long Term Debt And Capital Lease Obligations | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Liabilities | 13 | 11 | 12 | 10 | 14 | 10 | 9 | 9 | 8 | 8 | 8 | 10 | |||||
Preferred Stock Value | - | - | - | - | - | - | - | 0 | - | 0 | - | - | |||||
Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | 0 | - | - | - | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Share Subscribed But Unissued Subscri… | - | - | -0 | - | - | -0 | -0 | - | - | 0 | 0 | 4 | |||||
Stockholders Equity | |||||||||||||||||
Stockholders Equity | -10 | -7 | -8 | -6 | -10 | -6 | -5 | -4 | -3 | -3 | -2 | 5 | |||||
Stockholders Equity Note Subscriptions Receivable | -0 | -0 | - | -0 | -0 | - | - | -0 | -0 | - | - | - | |||||
Common Stock Held By Subsidiary | - | - | - | - | - | - | - | - | 0 | - | - | - | |||||
Additional Paid In Capital | 65 | 65 | 65 | 64 | 61 | 61 | 59 | 59 | 57 | 56 | 51 | 50 | |||||
Retained Earnings Accumulated Deficit | -75 | -72 | -72 | -70 | -71 | -67 | -64 | -63 | -61 | -60 | -58 | -50 | |||||
Liabilities And Stockholders Equity | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 14 | |||||
Series B Convertible Preferred Stock | - | - | - | -0 | 0 | 0 | - | - | - | - | - | - | |||||
Convertible Note Payable | - | - | - | 0 | 0 | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Convertible Note Payable Related Party | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | |||||
Debt Instrument Unamortized Discount | - | - | - | 2 | 2 | - | - | - | - | - | 1 | 1 | |||||
Convertible Note Payable Noncurrent | - | - | 0 | - | - | 0 | 0 | - | - | - | 0 | - | |||||
Convertible Notes Payable Non Current Related Part… | - | - | - | - | - | 0 | - | - | - | - | - | - | |||||
Interest Payable Current | - | - | 0 | - | - | - | 0 | - | - | - | 0 | - | |||||
Promissory Note Related Party | - | - | - | - | - | - | 0 | 0 | -0 | 0 | 0 | 0 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Convertible Notes Payable Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 4 | - | |||||
Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 1,000 | 1,000 | 1,000 | 1,000 | 300 | 300 | 1,000 | 300 | 300 | 300 | 300 | 300 | |||||
Common Stock Shares Issued | 294 | 278 | 246 | 238 | 228 | 224 | 192 | 185 | 163 | 152 | 138 | 136 | |||||
Shares Outstanding | 294 | 278 | 246 | 238 | 228 | 224 | 192 | 138 | 138 | 152 | 138 | 136 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -33.33% | 8.33% | 0.00% | -30.00% | -70.00% | -60.00% | - | - | - | - | - | - |
| 2023 | 65.00% | 70.00% | 25.00% | 8.00% | -16.00% | -28.00% | 23.53% | 0.00% | 11.76% | -28.57% | -42.86% | 0.00% |
| 2022 | -1.59% | -30.16% | -25.40% | 73.91% | 93.48% | 32.61% | -18.52% | -50.00% | -50.00% | -48.89% | -44.44% | -20.00% |
| 2021 | - | - | - | -2.33% | -29.88% | -30.03% | -23.32% | -32.69% | -64.42% | -40.91% | -24.55% | -54.55% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.00 | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 | 0.03 | 0.08 | 0.06 | 0.15 | 0.25 | 0.31 | |||||
| Quick Ratio | 0.00 | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 | 0.02 | 0.05 | 0.02 | 0.14 | 0.18 | 0.30 | |||||
| Working Capital | -6.55M | -4.71M | -5.82M | -4.25M | -8.27M | -4.81M | -3.29M | -2.91M | -2.54M | -2.86M | -1.94M | -1.09M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.39 | -1.53 | -1.54 | -1.68 | -1.44 | -1.66 | -1.87 | -2.02 | -2.41 | -2.48 | -3.28 | 2.07 | |||||
| Interest Coverage TTM | -5.69 | -2.49 | -3.15 | -3.59 | -4.46 | -24.11 | -2.84 | -6.52 | -7.67 | -8.33 | -56.40 | -38.37 | |||||
| Debt Ratio | 3.56 | 2.89 | 2.86 | 2.47 | 3.30 | 2.52 | 2.15 | 1.98 | 1.83 | 1.68 | 1.44 | 0.67 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.01 | -0.02 | - | -0.01 | -0.04 | -0.03 | - | - | -0.09 | - | - | - | |||||
| Free Cash Flow Per Share TTM | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | - | - | - | - | - | - | - | - | - | - | -18.88% | - | |||||
| Operating Profit Margin TTM | -2,497.01% | -2,869.29% | -6,960.98% | -9,106.71% | -14,763.89% | -25,998.35% | -52,425.60% | -182,235.37% | -101,413.17% | -51,202.59% | -23,114.45% | -15,500.40% | |||||
| Net Profit Margin TTM | -4,463.98% | -6,567.98% | -20,394.96% | -20,472.62% | -35,950.99% | -42,520.05% | -70,343.09% | -218,733.79% | -113,251.39% | -62,041.94% | -26,517.21% | -18,651.40% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 253.61% | 422.98% | 345.27% | 462.93% | 102.54% | -41.49% | -85.32% | -89.00% | -72.78% | -14.82% | - | -92.89% | |||||
| Net Income Growth (1Y) | -56.09% | -19.22% | 29.10% | -47.31% | -35.70% | -59.90% | -61.06% | 29.03% | 62.90% | 228.90% | 150.12% | 90.47% | |||||
| EPS Growth (1Y) | -66.26% | -35.11% | 1.02% | -61.02% | -55.97% | -72.84% | -72.06% | 2.00% | 39.85% | 176.86% | 126.99% | 75.49% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.71 | -0.60 | -0.58 | -0.69 | -0.77 | -0.74 | -0.86 | -1.28 | -0.59 | -1.12 | -3.73 | -7.33 | |||||
| P/B TTM | -0.31 | -0.45 | -0.61 | -0.82 | -0.74 | -0.83 | -1.12 | -3.92 | -2.53 | -5.62 | -25.57 | 16.37 | |||||
| P/S TTM | 31.78 | 39.26 | 118.24 | 141.57 | 276.34 | 316.12 | 607.14 | 2,807.35 | 670.76 | 691.84 | 989.04 | 1,367.37 | |||||
| Market Cap | 2.94M | 3.34M | 4.67M | 4.88M | 7.24M | 5.14M | 5.39M | 17.19M | 8.68M | 19.24M | 59.80M | 76.10M | |||||
| Enterprise Value | 3.13M | 3.45M | 6.33M | 4.97M | 7.25M | 5.10M | 6.74M | 22.60M | 14.15M | 24.33M | 66.15M | 81.99M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -761.83K | -1.14M | -1.03M | -1.37M | -1.42M | -1.49M | -2.05M | -2.59M | -2.82M | -2.71M | -2.57M | -2.33M | |||||
| Net Debt | 180.45K | 112.63K | 1.66M | 92.21K | 6.08K | -42.11K | 1.36M | 5.41M | 5.48M | 5.09M | 6.36M | 5.89M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
AXIM BIOTECHNOLOGIES, INC. (AXIM) — SEC Financial Statements & Analysis
AXIM BIOTECHNOLOGIES, INC. (AXIM) is a pharmaceutical preparations company, incorporated in NV. AXIM BIOTECHNOLOGIES, INC. trades on OTC as: AXIM. Based on its latest SEC filing (Form 10-Q, period ending 2024-06-30), AXIM BIOTECHNOLOGIES, INC. reported a 253.61% year-over-year revenue growth, a Gross Profit Margin of -18.88% (TTM), a Debt-to-Equity ratio of -1.39x, a Price-to-Sales (P/S) ratio of 31.78x (TTM), a Price-to-Book (P/B) ratio of -0.31x (TTM), at a market cap of $2.94M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 253.61%
- Gross Profit Margin TTM
- -18.88%
- Debt To Equity
- -1.39x
- P/S TTM
- 31.78x
- P/B TTM
- -0.31x
- Market Cap
- $2.94M
Data as of 2024-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is AXIM BIOTECHNOLOGIES, INC. in?
AXIM BIOTECHNOLOGIES, INC. (AXIM) operates in the Pharmaceutical Preparations industry.
What is AXIM's market cap?
AXIM BIOTECHNOLOGIES, INC. (AXIM) has a market capitalization of $2.94M as of 2024-06-30.
What exchange does AXIM trade on?
AXIM BIOTECHNOLOGIES, INC. (AXIM) trades on the OTC.
Where is AXIM BIOTECHNOLOGIES, INC. incorporated?
AXIM BIOTECHNOLOGIES, INC. is incorporated in NV.